Related references
Note: Only part of the references are listed.Design and synthesis of anti-breast cancer agents from 4-piperazinylquinoline: A hybrid pharmacophore approach
V. Raja Solomon et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000-2008
K. L. Vine et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
Hybrid pharmacophore design and synthesis of isatin-benzothiazole analogs for their anti-breast cancer activity
V. Raja Solomon et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Cancer Screening in the United States, 2009: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening
Robert A. Smith et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Design of New Drug Molecules to be Used in Reversing Multidrug Resistance in Cancer Cells
Y. C. Mayur et al.
CURRENT CANCER DRUG TARGETS (2009)
N-Phenethyl and N-naphthylmethyl isatins and analogues as in vitro cytotoxic agents
Lidia Matesic et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Targeted therapies in breast cancer
Federico Rojo et al.
SEMINARS IN DIAGNOSTIC PATHOLOGY (2008)
Design, synthesis, and biological testing of pyrazoline derivatives of combretastatin-A4
Marlie Johnson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Synthesis and antitumor activity of 1-substituted-2-methyl-5-nitrobenzimidazoles
Mostafa M. Ramla et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Synthesis and in vitro antitumor evaluation of some indeno[1,2-c]-pyrazol(in)es substituted with sulfonamide, sulfonylurea(-thiourea) pharmacophores, and some derived thiazole ring systems
Sherif A. F. Rostom
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma
RJ Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Novel benzimidazole derivatives selectively inhibit endothelial cell growth and suppress angiogenesis in vitro and in vivo
A Hori et al.
CANCER LETTERS (2002)
Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): Design, synthesis, enzymatic activities, and X-ray crystallographic analysis
HN Bramson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Share Paper
